Mettler-Toledo International Inc. Current Income Tax Expense (Benefit)
Mettler-Toledo International Inc. (MTD) reported Current Income Tax Expense (Benefit) of $162.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-06
- Mettler-Toledo International Inc. current income tax expense (benefit) for fiscal 2025 was $162.25M, a 9.51% decline from fiscal 2024.
- Mettler-Toledo International Inc. current income tax expense (benefit) for fiscal 2024 was $179.30M, a 9.59% decline from fiscal 2023.
- Mettler-Toledo International Inc. current income tax expense (benefit) for fiscal 2023 was $198.32M, a 15.59% increase from fiscal 2022.
- Mettler-Toledo International Inc. current income tax expense (benefit) for fiscal 2022 was $171.57M, a 4.58% decline from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 12 month | Current Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $162.25M 10-K · filed 2026-02-06 | |
| 2024-12-31 | $179.30M 10-K · filed 2026-02-06 | |
| 2023-12-31 | $198.32M 10-K · filed 2026-02-06 | |
| 2022-12-31 | $171.57M 10-K · filed 2025-02-07 | |
| 2021-12-31 | $179.81M 10-K · filed 2024-02-09 | |
| 2020-12-31 | $158.79M 10-K · filed 2023-02-10 | |
| 2019-12-31 | $124.92M 10-K · filed 2022-02-11 | |
| 2018-12-31 | $136.94M 10-K · filed 2021-02-08 | |
| 2017-12-31 | $201.00M 10-K · filed 2020-02-07 | |
| 2016-12-31 | $117.94M 10-K · filed 2019-02-08 | |
| 2015-12-31 | $103.47M 10-K · filed 2018-02-09 | $103.35M 10-K · filed 2016-02-04 |
| 2014-12-31 | $91.40M 10-K · filed 2017-02-02 | $93.73M 10-K · filed 2015-02-06 |
| 2013-12-31 | $87.80M 10-K · filed 2016-02-04 | |
| 2012-12-31 | $86.33M 10-K · filed 2015-02-06 | |
| 2011-12-31 | $77.09M 10-K · filed 2014-02-07 | |
| 2010-12-31 | $71.31M 10-K · filed 2013-02-08 | |
| 2009-12-31 | $48.40M 10-K · filed 2012-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |